IIT Projects Search

2023-2025
Pontil M., Bartolozzi C., Beccai L., Coletti C., De Vivo M., Del Bue A., Fellin T., Natale L., Parrinello M., Rocchia W., Sandini G., Sciutti A., Semini C., Wykowska A.
FAIR Future AI Research
Future AI Research
National
2023-2025
Di Filippo M.
AIRC Fellowship Post-Doc 2022 - Di Filippo
Novel Small Molecules Targeting the Spliceosome for Cancer Therapy
Foundation
2022-2025
Gustincich S., Armirotti A., Athanassiou A., Barberis A., Cancedda L., Cavalli A., De Pietri Tonelli D., De Vivo M., Diaspro A., Girotto S., Grimaldi B., Netti P., Nicassio F., Petrini E., Pompa P.P., Ruocco G., Siciliano V., Tartaglia G.G., Tirelli N., Tonini R., Tucci V., Vicidomini G.
National Center for Gene Therapy and Drugs based on RNA Technology
National Center for Gene Therapy and Drugs based on RNA Technology
National
2022-2025
Cavalli A., Armirotti A., Artyukhin S., Bencetti S., Ciraci' C., Crepaldi M., De Vivo M., Decherchi S., Girotto S., Gustincich S., Manna L., Nicassio F., Pontil M., Rocchia W., Succi S., Toma A.
National Centre for HPC, Big Data and Quantum Computing
National Centre for HPC, Big Data and Quantum Computing
National
2021-2023
Fumagalli A.
PSYNegrT
Deciphering the Negr1 interacting network in physiological conditions and in psychiatric and neurodevelopmental disorders.
European Ended
2020-2025
De Vivo M.
AIRC 2019 - DE VIVO
Development of novel small molecules that inhibit the growth of early stage melanoma tumors
Foundation
2020-2022
Sarkar A.
iCARE 2 - Sarkar
Dynamic docking simulations to optimize novel and potent anticancer inhibitors of human Topoisomerase II
Foundation Ended
2019-2021
Portioli C.
3D NKCC1
Interdisciplinary approach to characterize the structure and the ion transport mechanism of NKCC1, a key target for brain disorders.
European Ended
2019-2021
Pecina A.
CompNanozymes
Metal-dependent catalysis of nanozymes: First steps towards computational nanoenzymology
European Ended
2017-2020
De Vivo M.
AIRC 2016 De Vivo
Design and characterization of RhoJ Interaction Inhibitors as a Novel Therapy for Stage III Melanoma
Foundation Ended
2017-2019
Akkarapattiakal Kuriappan J.
Targeting Topo II
Mechanistic studies of metal-dependent DNA cleavage in Type II topoisomerase toward the rational design of novel anticancer drugs
European Ended
2014-2017
De Vivo M.
AIRC De Vivo
Acid ceramidase inhibition as a novel strategy to treat malignant melanoma
Foundation Ended